The Olaf S. Andersen Physician-Scientist Award was created to honor the legacy of Dr. Olaf S. Andersen, Program Director of the Tri-Institutional MD-PhD Program from 1996 - 2021. The award will be given annually, starting this year, to an MD-PhD student finishing their 3rd year of medical school.There are seven criteria for the award:
To encourage students from diverse backgrounds to join their ranks, physician-scientist communities must address the significant social, cultural and financial barriers many first-generation college students face in pursuing M.D.-Ph.D. careers, according to a new commentary authored by faculty, a student and staff in the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional M.D.–Ph.D. Program.
On April 8th Weill Cornell Graduate School held the 40th Annual du Vigneaud Research Symposium, this year via remote webcast.The one day symposium featured two poster sessions and two sessions of oral presentations by current WCGS students, along with a keynote address by Dr. Kevan Shokat, of UCSF.
Dr. Katharine (Kathy) Hsu, MD, PhD (Tri-I graduating class of 1994) has been named as the new director of the Tri-Institutional MD-PhD Program. Dr. Hsu, currently a professor at Weill Cornell Graduate School of Medical Sciences and attending hemotologist and oncologist at Memorial Sloan Kettering Cancer Center, where she leads her lab in the study of the ability of natural killer (NK) cells to fight cancer.
NEW YORK (April 9, 2021) — Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers, has been named director of the Tri-Institutional M.D.-Ph.D. Program, a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial Sloan Kettering Cancer Center.
The Tri-Institutional MD-PhD Program will graduate 13 students in 2021, all of whom have matched in the 2021 Residency Match.The 2021 matches are found below and all matches from 1991 through this year can be found here.
Molecular "bookmarks," which allow cells to retain their characteristics during cell division, ensure fast reactivation of critical cell identity genes after cell division, according to investigators at Weill Cornell Medicine. The new work helps illuminate a process that has puzzled biologists for decades and suggests new strategies for modulating cell fate both for stem cell therapy and cancer treatment.
The Tri-I MD-PhD Program is appalled by the disturbing trend of rising hate crimes directed against Asian-American communities. We express our direct and unwavering opposition to racially based violence, hatred, and discrimination in any form. We join the chorus of voices speaking out in opposition to such actions.